Scar-Degrading Endothelial Cells as a Treatment for Advanced Liver Fibrosis

In vivo, single intrasplenic injection of degrading liver sinusoidal endothelial cells (dLSECs) alleviated advanced liver fibrosis in mice, while intraperitoneal administration of liver-targeting peptide-modified dLSECs showed enhanced fibrosis-targeting effects.